Nephrologists should prioritize routine screening for metabolic markers including uric acid level, lipid profile, and inflammatory biomarkers (CRP, IL-6, TNF-α) in patients with early-stage CKD or those at risk of CKD. The gene discussed is TNF; the disease is chronic kidney disease.